from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0750/-

LFCtreatmentdescriptionclass of inhibitor

0.302

Amikacinug/mL Amikacintranslation

0.693

Cap5-10ug/mL Capreomycintranslation

1.381

Rox10-50 ug/mL Roxithromycintranslation

-0.365

SM2-5 ug/mL Streptomycintranslation

0.803

Tet5-10 ug/mL Tetracyclinetranslation

-1.491

Rif0.2-5ug/mL Rifampicintranscription

-1.924

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.821

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.444

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.321

CPZ10-50 ug/mL Chlorpromazinerespiration

0.207

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.678

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.239

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.265

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.970

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.576

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.136

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.618

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.140

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.361

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.458

KCN5-20 ug/mL Potassium cyaniderespiration

-0.030

NaN30.2-2 mM Sodium aziderespiration

-0.481

Nigericin50 uM Nigericinrespiration

0.219

TRC10-150 ug/mL Triclosanrespiration

1.361

TRZ10-25 ug/mL Thioridazinerespiration

2.649

Valinomycin0.5-10 uM Valinomycinrespiration

-0.202

ZnSO42 mM ZnSO4respiration

0.574

menadione6-10 ug/mL Menadionerespiration

-0.164

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.657

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.402

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.496

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.265

NRP_1Non-replicating persistence stage 1dosRassociated

-0.701

Amp0.2mg/mL AmpicillincellWall

-0.632

Cephalexin20-100 ug/mL CephalexincellWall

-0.641

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.827

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.543

EMB10-20 ug/mL EthambutolcellWall

-0.705

Eta12-40 ug/mL EthionamidecellWall

-0.106

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.598

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.117

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.831

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.745

BZA0.12 mg/mL BenzamidearomaticAmides

0.762

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.645

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.132

H2O24 mM hydrogen peroxideDNAdamaging

-0.724

Levo10 ug/mL LevofloxacinDNAdamaging

-0.375

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.045

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.847

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.411

UVUV-irradiationDNAdamaging

1.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.665

Antimycin12.5-50 ug/mL Antimycin A?

-0.889

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.213

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.361

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.350

PA8240.2-2 ug/mL PA-824?

0.350

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.332

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.214

Verapamil50 uM Verapamil?

-0.811

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.135

methoxatin10-20 ug/mL Methoxatin?